RUNX2 and spinal muscular atrophy: HDAC inhibitors have also been applied to the treatment of genetic diseases such as increased acetylation of Runx2 in a calvaria defect model of the Runx2 null mouse [23] and improving mRNA splicing to treat spinal muscular atrophy [5].